Formation of MacroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA R Zhang, MV Poustovoitov, X Ye, HA Santos, W Chen, SM Daganzo, ... Developmental cell 8 (1), 19-30, 2005 | 800 | 2005 |
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers BG Bitler, KM Aird, A Garipov, H Li, M Amatangelo, AV Kossenkov, ... Nature medicine 21 (3), 231-238, 2015 | 616 | 2015 |
Molecular dissection of formation of senescence-associated heterochromatin foci R Zhang, W Chen, PD Adams Molecular and cellular biology, 2007 | 463 | 2007 |
BET bromodomain inhibition promotes anti-tumor immunity by suppressing PD-L1 expression H Zhu, F Bengsch, N Svoronos, MR Rutkowski, BG Bitler, MJ Allegrezza, ... Cell reports 16 (11), 2829-2837, 2016 | 372 | 2016 |
sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance A Kaur, MR Webster, K Marchbank, R Behera, A Ndoye, CH Kugel, ... Nature 532 (7598), 250-254, 2016 | 353 | 2016 |
Microbially driven TLR5-dependent signaling governs distal malignant progression through tumor-promoting inflammation MR Rutkowski, TL Stephen, N Svoronos, MJ Allegrezza, AJ Tesone, ... Cancer cell 27 (1), 27-40, 2015 | 304 | 2015 |
Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence KM Aird, G Zhang, H Li, Z Tu, BG Bitler, A Garipov, H Wu, Z Wei, ... Cell reports 3 (4), 1252-1265, 2013 | 286 | 2013 |
NAD+ metabolism governs the proinflammatory senescence-associated secretome T Nacarelli, L Lau, T Fukumoto, J Zundell, N Fatkhutdinov, S Wu, KM Aird, ... Nature cell biology 21 (3), 397-407, 2019 | 272 | 2019 |
Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in BRCA-Mutant Ovarian Cancer Models H Kim, E George, RL Ragland, S Rafail, R Zhang, C Krepler, MA Morgan, ... Clinical Cancer Research 23 (12), 3097-3108, 2017 | 253 | 2017 |
Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells X Ye, B Zerlanko, A Kennedy, G Banumathy, R Zhang, PD Adams Molecular cell 27 (2), 183-196, 2007 | 244 | 2007 |
Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis AL Kennedy, JP Morton, I Manoharan, DM Nelson, NB Jamieson, ... Molecular cell 42 (1), 36-49, 2011 | 226 | 2011 |
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models H Kim, H Xu, E George, D Hallberg, S Kumar, V Jagannathan, ... Nature communications 11 (1), 3726, 2020 | 213 | 2020 |
ARID1A-mutated ovarian cancers depend on HDAC6 activity BG Bitler, S Wu, PH Park, Y Hai, KM Aird, Y Wang, Y Zhai, AV Kossenkov, ... Nature cell biology 19 (8), 962-973, 2017 | 213 | 2017 |
PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion MC Caino, JC Ghosh, YC Chae, V Vaira, DB Rivadeneira, A Faversani, ... Proceedings of the National Academy of Sciences 112 (28), 8638-8643, 2015 | 205 | 2015 |
Definition of pRB-and p53-dependent and-independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci X Ye, B Zerlanko, R Zhang, N Somaiah, M Lipinski, P Salomoni, ... Molecular and cellular biology, 2007 | 188 | 2007 |
Integrated analysis of genetic ancestry and genomic alterations across cancers J Yuan, Z Hu, BA Mahal, SD Zhao, KH Kensler, J Pi, X Hu, Y Zhang, ... Cancer cell 34 (4), 549-560. e9, 2018 | 183 | 2018 |
Structure and function of the conserved core of histone deposition protein Asf1 SM Daganzo, JP Erzberger, WM Lam, E Skordalakes, R Zhang, ... Current Biology 13 (24), 2148-2158, 2003 | 182 | 2003 |
Tumor cell–independent estrogen signaling drives disease progression through mobilization of myeloid-derived suppressor cells N Svoronos, A Perales-Puchalt, MJ Allegrezza, MR Rutkowski, KK Payne, ... Cancer discovery 7 (1), 72-85, 2017 | 180 | 2017 |
Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B S Rao, SY Lee, A Gutierrez, J Perrigoue, RJ Thapa, Z Tu, JR Jeffers, ... Blood, The Journal of the American Society of Hematology 120 (18), 3764-3773, 2012 | 166 | 2012 |
BET bromodomain inhibition synergizes with PARP inhibitor in epithelial ovarian cancer S Karakashev, H Zhu, Y Yokoyama, B Zhao, N Fatkhutdinov, ... Cell reports 21 (12), 3398-3405, 2017 | 162 | 2017 |